Correlation Between Pieris Pharmaceuticals and CytomX Therapeutics
Can any of the company-specific risk be diversified away by investing in both Pieris Pharmaceuticals and CytomX Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pieris Pharmaceuticals and CytomX Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pieris Pharmaceuticals and CytomX Therapeutics, you can compare the effects of market volatilities on Pieris Pharmaceuticals and CytomX Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pieris Pharmaceuticals with a short position of CytomX Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pieris Pharmaceuticals and CytomX Therapeutics.
Diversification Opportunities for Pieris Pharmaceuticals and CytomX Therapeutics
0.49 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Pieris and CytomX is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Pieris Pharmaceuticals and CytomX Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CytomX Therapeutics and Pieris Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pieris Pharmaceuticals are associated (or correlated) with CytomX Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CytomX Therapeutics has no effect on the direction of Pieris Pharmaceuticals i.e., Pieris Pharmaceuticals and CytomX Therapeutics go up and down completely randomly.
Pair Corralation between Pieris Pharmaceuticals and CytomX Therapeutics
Given the investment horizon of 90 days Pieris Pharmaceuticals is expected to generate 2.39 times less return on investment than CytomX Therapeutics. But when comparing it to its historical volatility, Pieris Pharmaceuticals is 2.13 times less risky than CytomX Therapeutics. It trades about 0.02 of its potential returns per unit of risk. CytomX Therapeutics is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 135.00 in CytomX Therapeutics on August 24, 2024 and sell it today you would lose (46.42) from holding CytomX Therapeutics or give up 34.39% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pieris Pharmaceuticals vs. CytomX Therapeutics
Performance |
| Timeline |
| Pieris Pharmaceuticals |
| CytomX Therapeutics |
Pieris Pharmaceuticals and CytomX Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pieris Pharmaceuticals and CytomX Therapeutics
The main advantage of trading using opposite Pieris Pharmaceuticals and CytomX Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pieris Pharmaceuticals position performs unexpectedly, CytomX Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CytomX Therapeutics will offset losses from the drop in CytomX Therapeutics' long position.| Pieris Pharmaceuticals vs. CytomX Therapeutics | Pieris Pharmaceuticals vs. Instil Bio | Pieris Pharmaceuticals vs. Spero Therapeutics | Pieris Pharmaceuticals vs. Assembly Biosciences |
| CytomX Therapeutics vs. Lyra Therapeutics | CytomX Therapeutics vs. Hookipa Pharma | CytomX Therapeutics vs. Cingulate Warrants | CytomX Therapeutics vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Complementary Tools
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |